Showing results (611-620 of 2,790) with videos related to
Sort By:
Pageof 279
Journal of Veterinary Pharmacology and Therapeutics|March 8, 2023
Concentrations, pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites following oral administration to horsesMeghan K M Poth, Daniel S McKemie, Megan Traynham, et al.Journal of Veterinary Pharmacology and Therapeutics|June 1, 1985
Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparisonD Schwartz-Porsche, W Löscher, H H FreyJournal of Veterinary Pharmacology and Therapeutics|June 1, 1985
Furazolidone concentrations in plasma, milk and some tissues of Nubian goatsA I Mustafa, B H Ali, T Hassan, et al.Journal of Veterinary Pharmacology and Therapeutics|February 23, 2023
Pharmacokinetics of intra-articular buprenorphine in horses with lipopolysaccharide-induced synovitisGabriel Castro-Cuellar, Jeannette Cremer, Patricia Queiroz-Williams, et al.Journal of Veterinary Pharmacology and Therapeutics|February 28, 2025
Safety of the Selective JAK1 Inhibitor Oclacitinib in DogsSteven M Nederveld, Matthew J Krautmann, John MitchellJournal of Veterinary Pharmacology and Therapeutics|November 13, 2024
The Single-Dose Pharmacokinetics of a Compounded Levetiracetam Formulation and Bioequivalence to a Commercial Formulation in Healthy DogsAaron M Paushter, Kari D Foss, Jennifer M Reinhart, et al.Journal of Veterinary Pharmacology and Therapeutics|November 12, 2024
Antimicrobial Pharmacokinetic Studies in Sea Turtles: A ReviewEric F Egelund, Alana Jula, Kathleen Rish, et al.Journal of Veterinary Pharmacology and Therapeutics|November 27, 2024
Efficacy of Procaine, With and Without Epinephrine, Compared to Lidocaine in Local Anesthesia for Calves Before Thermocautery DisbuddingMagdy Adam, Annemari Jokela, Kati Salla, et al.Journal of Veterinary Pharmacology and Therapeutics|August 24, 2024
Analysis of US Marketed Artemisinin Supplements for Use in DogsAlyssa R Berman, Adam J Birkenheuer, Emily L Sorah, et al.Journal of Veterinary Pharmacology and Therapeutics|June 27, 2024
Oclacitinib (APOQUEL®) is a selective Janus kinase 1 inhibitor with efficacy in a canine model of flea allergic dermatitisAndrea J Gonzales, Michelle Aleo, Sean Mahabir, et al.Pageof 279